Crossref
Messenger RNA Vaccine Technology: Success for SARS-CoV-2 and Prospects for an HIV-1 Vaccine
Topics in Antiviral Medicine · 01.04.2024 · 32 (2) · 420-430
DOI: 10.68040/2024322.420430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Topics in Antiviral Medicine, 2024-04. Verfasst von Jacob K. Files und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Files, J. K., & Goepfert, P. A. (2024). Messenger RNA Vaccine Technology: Success for SARS-CoV-2 and Prospects for an HIV-1 Vaccine. Topics in Antiviral Medicine, 32(2), 420-430. https://doi.org/10.68040/2024322.420430
Vancouver
Files JK, Goepfert PA. Messenger RNA Vaccine Technology: Success for SARS-CoV-2 and Prospects for an HIV-1 Vaccine. Topics in Antiviral Medicine. 2024;32(2):420-430. doi:10.68040/2024322.420430
BibTeX
@article{Files2024,
author = {Files, Jacob K. and Goepfert, Paul A.},
title = {Messenger RNA Vaccine Technology: Success for SARS-CoV-2 and Prospects for an HIV-1 Vaccine},
journal = {Topics in Antiviral Medicine},
year = {2024},
volume = {32},
number = {2},
pages = {420--430},
doi = {10.68040/2024322.420430}
}
EUVIMED